Hogg Ruth, Chakravarthy Usha
Ophthalmology & Vision Science, Institute of Clinical Science, The Royal Victoria Hospital, Belfast, Northern Ireland.
Curr Eye Res. 2004 Dec;29(6):387-401. doi: 10.1080/02713680490517890.
Age-related maculopathy (ARM) is a common clinical entity. The late-stage manifestations of ARM, which are known as age-related macular degeneration (AMD), have devastating consequences for vision. Various risk factors have been identified in the development of the condition, which are consistent with the premise that oxidative stress plays an important role in its pathogenesis. Thus, the possibility that antioxidant balance can be manipulated through diet or supplementation has created much interest. Associations between diet and nutrition and the clinical features of ARM have been described. Scrutiny of the literature shows consistency in the report of notable reductions in serum micronutrients in wet AMD, however, the evidence for causation is still circumstantial. In this comprehensive review of the clinical literature, we have assessed the evidence for a link between diet and nutrition as risk factors for the development of ARM and AMD. All published case control, population-based, and interventional studies on ARM were examined. Although initial support appeared to be moderate and somewhat contradictory, the evidence that lifetime oxidative stress plays an important role in the development of ARM is now compelling. The positive outcomes in the Age-Related Eye Diseases Study, a major controlled clinical trial, have given hope that modulation of the antioxidant balance through supplementation can help prevent progression of ARM to AMD.
年龄相关性黄斑病变(ARM)是一种常见的临床病症。ARM的晚期表现,即年龄相关性黄斑变性(AMD),会对视力造成毁灭性后果。在该病症的发展过程中已确定了多种风险因素,这与氧化应激在其发病机制中起重要作用的前提相一致。因此,通过饮食或补充剂来调节抗氧化平衡的可能性引起了人们的极大兴趣。饮食与营养和ARM临床特征之间的关联已有描述。对文献的仔细审查表明,湿性AMD患者血清微量营养素显著降低的报道具有一致性,然而,因果关系的证据仍然是间接的。在对临床文献的这一全面综述中,我们评估了饮食和营养作为ARM和AMD发展风险因素之间存在关联的证据。我们审查了所有已发表的关于ARM的病例对照研究、基于人群的研究和干预性研究。尽管最初的支持似乎力度适中且有些矛盾,但目前有令人信服的证据表明终生氧化应激在ARM的发展中起重要作用。一项大型对照临床试验——年龄相关性眼病研究的积极结果给人们带来了希望,即通过补充剂调节抗氧化平衡有助于预防ARM进展为AMD。